Man

Jeffri Stevens Retamal Santibañez

Profesor asistente

Universidad de Santiago de Chile

Santiago, Chile

Líneas de Investigación


Bioquímico, doctor en Ciencias Farmacéuticas y Farmacología, con énfasis en señalización de biología celular/farmacólogo. Científico experimentado, experto en señalización del dolor y farmacología de receptores acoplados a proteína G (GPCR), con más

Educación

  •  Farmacologia y ciencias farmaceuticas, MONASH UNIVERSITY. Australia, 2021
  •  Bioquimica, UNIVERSIDAD ANDRES BELLO. Chile, 2013
  •  Bioquimico, UNIVERSITE DE MONS-HAINAUT. Chile, 2010

Experiencia Académica

  •   Asistente de investigación Full Time

    UNIVERSIDAD DE SANTIAGO DE CHILE

    Quimica y biologia

    Chile

    2013 - A la fecha

  •   research assistant Full Time

    MONASH UNIVERSITY

    Pharmaceutical science

    Melbourne, Australia

    2016 - A la fecha

  •   Postdoctoral Full Time

    MONASH UNIVERSITY

    Pharmacy and Pharmaceutical science

    Melbourne, Australia

    2020 - 2021

  •   Research associate Full Time

    NEW YORK UNIVERSITY

    Dentistry

    New York, Estados Unidos

    2021 - 2023

Premios y Distinciones

  •   Best publication

    MONASH UNIVERSITY

    Australia, 2020

    Best publication in the faculty, 2020 Ph-responsive nanoparticles, Published in nature nanotechnology

  •   Beca Chile para doctorado en el extrajero

    MONASH UNIVERSITY

    Chile, 2017

    Beca chile para doctorado en el extrajero


 

Article (12)

Acaricidal activity of geraniol-loaded lignin nanoparticles for the control of Brevipalpus chilensis: an eco-friendly approach to crop protection
N-methyl-D-aspartate receptor activation is downstream coupled to pannexin 1 opening by Src kinase in dorsal horn neurons: an essential link for mechanical hyperalgesia in nerve-injured rats
Mice expressing fluorescent PAR<sub>2</sub> reveal that endocytosis mediates colonic inflammation and pain
NMDA and P2X7 Receptors Require Pannexin 1 Activation to Initiate and Maintain Nociceptive Signaling in the Spinal Cord of Neuropathic Rats
Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain
A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes
Serotonin-induced vascular permeability is mediated by transient receptor potential vanilloid 4 in the airways and upper gastrointestinal tract of mice
The transient receptor potential vanilloid 4 (TRPV4) ion channel mediates protease activated receptor 1 (PAR1)-induced vascular hyperpermeability
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain
Burst-Like Subcutaneous Electrical Stimulation Induces BDNF-Mediated, Cyclotraxin B-Sensitive Central Sensitization in Rat Spinal Cord
Pannexin 1: A novel participant in neuropathic pain signaling in the rat spinal cord

Proyecto (5)

Endosomal platforms for neuropeptide receptor signaling.
New materials for manipulating intracellular communication
The Importance of Receptor Trafficking for Signalling of Pain and Inflammation
Endosomal drug delivery systems=> Targeting pain at the source
ROLE OF SPINAL CORD LTP IN THE TRIGGERING AND MAINTENANCE OF CHRONIC PAIN=> A LONG-LASTING STUDY IN THE RAT.

Review (1)

Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain
1
HECTOR BURGOS

INVESTIGADOR

FACULTAD DE CIENCIAS

UNIVERSIDAD SANTO TOMÁS, Chile

SANTIAGO, Chile

4
Luis Constandil

Profesor Titular

Biología

Universidad de Santiago de Chile

Santiago, Chile

2
David Bravo

CEO

Research and Innovation

Pannex Therapeutics

Santiago, Chile

13
Jeffri Retamal

Profesor asistente

Biologia

Universidad de Santiago de Chile

Santiago, Chile